The Baxter-Bazhanov-Stroganov model (also known as the τ (2) model) has attracted much interest because it provides a tool for solving the integrable chiral Z N -Potts model. It can be formulated as a face spin model or via cyclic L-operators. Using the latter formulation and the Sklyanin-Kharchev-Lebedev approach, we give the explicit derivation of the eigenvectors of the component B n (λ) of the monodromy matrix for the fully inhomogeneous chain of finite length. For the periodic chain we obtain the Baxter T-Q-equations via separation of variables. The functional relations for the transfer matrices of the τ (2) model guarantee non-trivial solutions to the Baxter equations. For the N = 2 case, which is free fermion point of a generalized Ising model, the Baxter equations are solved explicitly.
We continue our investigation of the Z N -Baxter-Bazhanov-Stroganov model using the method of separation of variables [1]. In this paper we calculate the norms and matrix elements of a local Z N -spin operator between eigenvectors of the auxiliary problem. For the norm the multiple sums over the intermediate states are performed explicitly. In the case N = 2 we solve the Baxter equation and obtain form-factors of the spin operator of the periodic Ising model on a finite lattice.
We continue our investigation of the Baxter-Bazhanov-Stroganov or τ (2)model using the method of separation of variables [1,2]. In this paper we derive for the first time the factorized formula for form-factors of the Ising model on a finite lattice conjectured previously by A. Bugrij and O. Lisovyy in [3,4]. We also find the matrix elements of the spin operator for the finite quantum Ising chain in a transverse field.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.